| The concise guide to pharmacology 2021/22: Enzymes SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British journal of pharmacology 178, S313-S411, 2021 | 370 | 2021 |
| Top notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives G Moore, S Annett, L McClements, T Robson Cells 9 (6), 1503, 2020 | 103 | 2020 |
| Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages JK Dowling, R Afzal, LJ Gearing, MP Cervantes-Silva, S Annett, GM Davis, ... Nature communications 12 (1), 1460, 2021 | 88 | 2021 |
| Targeting cancer stem cells in the clinic: Current status and perspectives S Annett, T Robson Pharmacology & therapeutics 187, 13-30, 2018 | 82 | 2018 |
| FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention S Annett, G Moore, T Robson Pharmacology & Therapeutics 215, 107623, 2020 | 60 | 2020 |
| FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4 L McClements, S Annett, A Yakkundi, M O’Rourke, A Valentine, ... BMC cancer 19, 1-14, 2019 | 53 | 2019 |
| The concise guide to PHARMACOLOGY 2023/24: enzymes SPH Alexander, D Fabbro, E Kelly, AA Mathie, JA Peters, EL Veale, ... British journal of pharmacology 180, S289-S373, 2023 | 50 | 2023 |
| Obesity and cancer metastasis: molecular and translational perspectives S Annett, G Moore, T Robson Cancers 12 (12), 3798, 2020 | 48 | 2020 |
| FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer S Annett, G Moore, A Short, A Marshall, C McCrudden, A Yakkundi, S Das, ... British Journal of Cancer 122 (3), 361-371, 2020 | 43 | 2020 |
| Potentiating the anticancer properties of bisphosphonates by nanocomplexation with the cationic amphipathic peptide, RALA AS Massey, S Pentlavalli, R Cunningham, CM McCrudden, EM McErlean, ... Molecular pharmaceutics 13 (4), 1217-1228, 2016 | 35 | 2016 |
| Prognostic significance of glucocorticoid receptor expression in cancer: A systematic review and meta-analysis N Bakour, F Moriarty, G Moore, T Robson, SL Annett Cancers 13 (7), 1649, 2021 | 19 | 2021 |
| The role of peptidyl prolyl isomerases in aging and vascular diseases L McClements, S Annett, A Yakkundi, T Robson Current molecular pharmacology 9 (2), 165-179, 2016 | 19 | 2016 |
| The cancer stem cell niche in ovarian cancer and its impact on immune surveillance S Jain, SL Annett, MP Morgan, T Robson International Journal of Molecular Sciences 22 (8), 4091, 2021 | 18 | 2021 |
| Pharmaceutical drug development: high drug prices and the hidden role of public funding S Annett Biologia Futura 72 (2), 129-138, 2021 | 14 | 2021 |
| The immunophilin protein FKBPL and its peptide derivatives are novel regulators of vascular integrity and inflammation via NF-κB signaling S Annett, S Spence, C Garciarena, C Campbell, M Dennehy, C Drakeford, ... bioRxiv, 2021.02. 24.431422, 2021 | 7 | 2021 |
| Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype C De Santi, FK Nally, R Afzal, CP Duffy, S Fitzsimons, SL Annett, ... Molecular Therapy-Nucleic Acids 29, 643-655, 2022 | 6 | 2022 |
| Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors SA Kennedy, SL Annett, MR Dunne, F Boland, LM O’Neill, EM Guinan, ... Frontiers in Oncology 11, 669078, 2021 | 3 | 2021 |
| Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability AM Rehill, G Leon, S McCluskey, I Schoen, Y Hernandez-Santana, ... Journal of Thrombosis and Haemostasis 22 (2), 394-409, 2024 | 2 | 2024 |
| Dexamethasone promotes breast cancer stem cells in obese and not lean mice S Annett, OW Fox, D Vareslija, T Robson Pharmacology Research & Perspectives 10 (2), e00923, 2022 | 2 | 2022 |
| Peptidyl-prolyl cis/trans isomerases in GtoPdb v. 2023.1 S Annett, T Robson IUPHAR/BPS Guide to Pharmacology CITE 2023 (1), 2023 | | 2023 |
